Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...
Eisai Co., Ltd. and Purdue Pharma L.P. announced they will present the latest data from two key Phase I clinical studies...
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...
Singapore – Results published in the International Journal of Cardiology show that the 0-hour/1-hou...
Japan's Takeda Pharmaceutical recently announced it has entered into an agreement to sell its majority shareholding...
A special health ministry panel gave Osaka University the approval to carry out a study involving the use of induce...
Platelet BioGenesis, a pioneer in the production of functional human platelets from stem cells, has announced it has lic...
Kaneka Corporation, the Japan based chemical manufacturing company, is set to appeal to the District Court for the Centr...
Aquinox Pharmaceuticals, a clinical-stage pharmaceutical company discovering and developing novel drug candidate...
Singapore– Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) a...
Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) tr...
Aspirin can counter the ill effects of obesity on cancer development, according to a study that may pave the way for new...
Takeda Pharmaceutical Co. reached a preliminary agreement to buy Shire Plc with takeover offer of about 46 billion pound...
Japan based Aska Pharmaceuticals Co. and Omnicare Drugs India Pvt Ltd, a 100 per cent subsidiary of the UAE's largest ph...
Taiwan and Japan authorities have urged locals and tourists to take added precautions following an outbreak of measles. ...
Singapore- Japan’s Astellas Pharma and Kite Pharma, a Gilead Sciences subsidiary announced that an agreement has b...
Singapore- Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan's Taked...
The engineering and IT conglomerate Hitachi is poised to carry out what it hailed as the world’s first experiment ...
